Abstract
Introduction: This study aims to assess the efficacy of silver nanoparticles (Ag Nps) alone
and combined with metronidazole (Ag Nps + MTZ) as potential alternative therapeutic
agents for Blastocystis hominis.
Methods: The parasites were challenged with Ag Nps, Ag Nps + MTZ and MTZ. To assess the efficacy of drugs, counting of viable parasites was done after 1, 2, and 3 hours of adding the drugs.
Results: Blastocystis hominis count was reduced by 20.72%, 28.23%, and 18.92% after one hour of adding Ag Nps, Ag Nps + MTZ, and MTZ, respectively. Cysts count was further reduced by 51.49%, 61.61%, and 40.78% after 2 hours and by 71.69%, 79.67%, and 62.65% after 3 hours of adding the drugs in the same order, respectively.
Conclusion: There was a statistically significant difference (P<0.05) in the in vitro growth inhibition of the parasite over the different time intervals when using the tested drugs against the control drug.
Methods: The parasites were challenged with Ag Nps, Ag Nps + MTZ and MTZ. To assess the efficacy of drugs, counting of viable parasites was done after 1, 2, and 3 hours of adding the drugs.
Results: Blastocystis hominis count was reduced by 20.72%, 28.23%, and 18.92% after one hour of adding Ag Nps, Ag Nps + MTZ, and MTZ, respectively. Cysts count was further reduced by 51.49%, 61.61%, and 40.78% after 2 hours and by 71.69%, 79.67%, and 62.65% after 3 hours of adding the drugs in the same order, respectively.
Conclusion: There was a statistically significant difference (P<0.05) in the in vitro growth inhibition of the parasite over the different time intervals when using the tested drugs against the control drug.
| Original language | English |
|---|---|
| Pages (from-to) | 8167-8173 |
| Number of pages | 7 |
| Journal | International Journal of Nanomedicine |
| Volume | 15 |
| Early online date | 1 Sept 2020 |
| DOIs | |
| Publication status | Published (in print/issue) - 22 Oct 2020 |
Data Access Statement
All data are available from the corresponding author upon request.Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Keywords
- Blastocystis hominis
- eosin brilliant cresyl blue stain
- metronidazole
- Silver nanoparticles